Omadacycline-Associated Pancreatic Injury: a Spectrum from Mild Interstitial to Recrudescent Pancreatitis with Pharmacovigilance Implications
Guanghui Chen, Qiang Qu, Lishan Yi, Yanyan Zhou, Jian Qu · 2026
Read Omadacycline-Associated Pancreatic Injury: a Spectrum from Mild Interstitial to Recrudescent Pancreatitis with Pharmacovigilance Implications by Guanghui Chen, Qiang Qu, Lishan Yi, Yanyan Zhou, Jian Qu (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13658659.txt.
Description
Guanghui Chen and his team report three cases of harm to the pancreas linked to a drug called omadacycline, in two thousand twenty-six. The drug is a newer germ-fighting drug. Its safety record is still not well known, and harm of this kind had been reported just once before.
All three patients were in intensive care and showed high levels of a pancreas enzyme. Scans showed harm that ranged from mild swelling to a flare in one part of the gland. Other common causes were ruled out in each case. All three got better once the drug was stopped. The team urges doctors to watch for this harm and report new cases.
Catalog record
| CREATOR | Guanghui Chen, Qiang Qu, Lishan Yi, Yanyan Zhou, Jian Qu |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 25 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |